Innovation
Circular Economy: Ideas to Business - in person event
Mewburn Ellis is delighted to be partnering with Oxfordshire Greentech to present another exciting in person event in our successful series “Operating in the circular economy: Ideas to Business”. Join us at Saïd Business School, Oxford on Thursday 7 December 2023, t...
State of the art searching for patentability and beyond
Join an online training course on 12 and 13 October to learn when and how to perform a ‘state of the art’ patent search. https://ipi.academy/product/details/2601/state-of-the-art-searching ...
Alchemie Technology joins forces with 42nd Cambridge Film Festival to champion environmental causes
Alchemie Technology, a leader in clean-tech solutions for textile dyeing and finishing, is teaming up with the 42nd Cambridge Film Festival as the proud sponsor of the Environment & Community section. Alchemie's dedication to a pollution-free world and the preservation of water reso...
Portsmouth Aviation and 42 Technology collaborate to bring Exovent ventilator to market
UK manufacturer Portsmouth Aviation has appointed 42 Technology (42T) as a strategic development partner to help bring its unique Exovent negative pressure ventilator (NPV) system to market. ...
Webinar: Metabolism prediction, 3D virtual screening and more – meet StarDrop 7.5
Want to discover next generation drug discovery software? Join Optibrium’s Chief Scientific Officer Ed Champness to explore the exciting new features in the latest release of StarDrop, built to elevate your drug discovery projects. These include: ...
Optibrium releases powerful metabolism prediction capability in next generation StarDrop software
Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, launches the latest version of its drug discovery platform, StarDrop 7.5, introducing a powerful module for drug metabolism prediction. ...
Ion channel drug developer Maxion Therapeutics appoints Eva-Lotta Allan as Chair of its Board of Directors
Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announced the appointment of senior industry leader Eva-Lotta Allan as the Chair of its Board of Directors. The announcement comes ...
Planning your diagnostic product roadmap: from Gen 1 to Gen 2
In an ideal world, the first product a company launches would deliver everything they had envisioned. The device capability would satisfy all functional requirements, serve all target user groups and disrupt markets on the international stage. Unfortunately, the path to launch and beyon...
Digital technologies that could revolutionise healthcare
From speech analytics and automation capabilities to deep learning platforms, there are many emerging digital technologies being used across industries to enhance customer experience. When applied in healthcare, these technologies have the potential to address a number of challenges for...
5 revolutionary women’s health innovations
Over recent years, advancements in medical technology have had a profound impact on healthcare, from improving diagnostics, to enhancing treatment options. The following examples are five game-changing women’s health medical devices that have empowered women to lead healthier, more fulf...